vs
Side-by-side financial comparison of Danaos Corp (DAC) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.
Danaos Corp is the larger business by last-quarter revenue ($262.2M vs $207.8M, roughly 1.3× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 49.9%, a 7.4% gap on every dollar of revenue.
Danaos Corporation is a leading global containership ownership and management firm. It operates a large fleet of modern container vessels, providing long-term charter services to top international container liner operators across major global trade routes, supporting the efficiency and reliability of global supply chains.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
DAC vs IDYA — Head-to-Head
Income Statement — Q2 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $262.2M | $207.8M |
| Net Profit | $130.9M | $119.2M |
| Gross Margin | — | — |
| Operating Margin | 47.9% | 52.2% |
| Net Margin | 49.9% | 57.4% |
| Revenue YoY | 6.4% | — |
| Net Profit YoY | -7.3% | 330.1% |
| EPS (diluted) | $7.12 | $1.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $207.8M | ||
| Q2 25 | $262.2M | — | ||
| Q3 24 | — | $0 | ||
| Q2 24 | $246.3M | $0 | ||
| Q1 24 | — | $0 | ||
| Q2 23 | $241.5M | — | ||
| Q3 22 | — | $29.7M | ||
| Q2 22 | $250.9M | — |
| Q3 25 | — | $119.2M | ||
| Q2 25 | $130.9M | — | ||
| Q3 24 | — | $-51.8M | ||
| Q2 24 | $141.2M | $-52.8M | ||
| Q1 24 | — | $-39.6M | ||
| Q2 23 | $147.0M | — | ||
| Q3 22 | — | $1.6M | ||
| Q2 22 | $8.2M | — |
| Q3 25 | — | 52.2% | ||
| Q2 25 | 47.9% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 56.8% | — | ||
| Q1 24 | — | — | ||
| Q2 23 | 61.1% | — | ||
| Q3 22 | — | 2.2% | ||
| Q2 22 | 62.5% | — |
| Q3 25 | — | 57.4% | ||
| Q2 25 | 49.9% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 57.3% | — | ||
| Q1 24 | — | — | ||
| Q2 23 | 60.9% | — | ||
| Q3 22 | — | 5.4% | ||
| Q2 22 | 3.3% | — |
| Q3 25 | — | $1.33 | ||
| Q2 25 | $7.12 | — | ||
| Q3 24 | — | $-0.60 | ||
| Q2 24 | $7.23 | $-0.68 | ||
| Q1 24 | — | $-0.53 | ||
| Q2 23 | $7.32 | — | ||
| Q3 22 | — | $0.04 | ||
| Q2 22 | $0.40 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $654.1M | $786.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $3.6B | $1.1B |
| Total Assets | $4.5B | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $786.9M | ||
| Q2 25 | $654.1M | — | ||
| Q3 24 | — | $920.0M | ||
| Q2 24 | $471.7M | $701.7M | ||
| Q1 24 | — | $698.8M | ||
| Q2 23 | $367.9M | — | ||
| Q3 22 | — | $386.2M | ||
| Q2 22 | $319.6M | — |
| Q3 25 | — | $1.1B | ||
| Q2 25 | $3.6B | — | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | $3.3B | $931.7M | ||
| Q1 24 | — | $935.3M | ||
| Q2 23 | $2.8B | — | ||
| Q3 22 | — | $368.8M | ||
| Q2 22 | $2.4B | — |
| Q3 25 | — | $1.2B | ||
| Q2 25 | $4.5B | — | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | $4.0B | $973.7M | ||
| Q1 24 | — | $961.5M | ||
| Q2 23 | $3.5B | — | ||
| Q3 22 | — | $410.9M | ||
| Q2 22 | $3.7B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $142.2M |
| Free Cash FlowOCF − Capex | — | $142.2M |
| FCF MarginFCF / Revenue | — | 68.4% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | — | $13.5M |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $142.2M | ||
| Q2 25 | — | — | ||
| Q3 24 | — | $-49.2M | ||
| Q2 24 | — | $-32.9M | ||
| Q1 24 | — | $-43.8M | ||
| Q2 23 | — | — | ||
| Q3 22 | — | $-24.2M | ||
| Q2 22 | — | — |
| Q3 25 | — | $142.2M | ||
| Q2 25 | — | — | ||
| Q3 24 | — | $-49.7M | ||
| Q2 24 | — | $-33.9M | ||
| Q1 24 | — | $-45.1M | ||
| Q2 23 | — | — | ||
| Q3 22 | — | $-25.3M | ||
| Q2 22 | — | — |
| Q3 25 | — | 68.4% | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q2 23 | — | — | ||
| Q3 22 | — | -85.1% | ||
| Q2 22 | — | — |
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q2 23 | — | — | ||
| Q3 22 | — | 3.7% | ||
| Q2 22 | — | — |
| Q3 25 | — | 1.19× | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q2 23 | — | — | ||
| Q3 22 | — | -14.96× | ||
| Q2 22 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
